Department of Nanophysics, Istituto Italiano di Tecnologia, Genova, Italy; DIBRIS Department, University of Genova, Genova, Italy.
Department of Nanophysics, Istituto Italiano di Tecnologia, Genova, Italy.
Biophys J. 2018 Mar 27;114(6):1357-1367. doi: 10.1016/j.bpj.2018.02.003.
The deposition of fibrillar protein aggregates in human organs is the hallmark of several pathological states, including highly debilitating neurodegenerative disorders and systemic amyloidoses. It is widely accepted that small oligomers arising as intermediates in the aggregation process, released by fibrils, or growing in secondary nucleation steps are the cytotoxic entities in protein-misfolding diseases, notably neurodegenerative conditions. Increasing evidence indicates that cytotoxicity is triggered by the interaction between nanosized protein aggregates and cell membranes, even though little information on the molecular details of such interaction is presently available. In this work, we propose what is, to our knowledge, a new approach, based on the use of single-cell force spectroscopy applied to multifunctional substrates, to study the interaction between protein oligomers, cell membranes, and/or the extracellular matrix. We compared the interaction of single Chinese hamster ovary cells with two types of oligomers (toxic and nontoxic) grown from the N-terminal domain of the Escherichia coli protein HypF. We were able to quantify the affinity between both oligomer type and the cell membrane by measuring the mechanical work needed to detach the cells from the aggregates, and we could discriminate the contributions of the membrane lipid and protein fractions to such affinity. The fundamental role of the ganglioside GM1 in the membrane-oligomers interaction was also highlighted. Finally, we observed that the binding of toxic oligomers to the cell membrane significantly affects the functionality of adhesion molecules such as Arg-Gly-Asp binding integrins, and that this effect requires the presence of the negatively charged sialic acid moiety of GM1.
纤维状蛋白聚集体在人类器官中的沉积是几种病理状态的标志,包括高度衰弱的神经退行性疾病和系统性淀粉样变性。人们普遍认为,在聚合过程中作为中间体产生的小寡聚体、由纤维释放或在二级成核步骤中生长的寡聚体是蛋白质错误折叠疾病(尤其是神经退行性疾病)中的细胞毒性实体。越来越多的证据表明,细胞毒性是由纳米级蛋白聚集体与细胞膜之间的相互作用触发的,尽管目前关于这种相互作用的分子细节的信息很少。在这项工作中,我们提出了一种新的方法,这在我们的知识范围内是一种新的方法,该方法基于使用单细胞力谱技术应用于多功能底物,来研究蛋白寡聚物、细胞膜和/或细胞外基质之间的相互作用。我们比较了两种类型的寡聚体(有毒和无毒)与从大肠杆菌蛋白 HypF 的 N 端结构域生长的单个中国仓鼠卵巢细胞之间的相互作用。我们能够通过测量将细胞从聚集体上分离所需的机械功来量化两种寡聚体类型与细胞膜之间的亲和力,并且我们可以区分膜脂质和蛋白部分对这种亲和力的贡献。神经节苷脂 GM1 在膜-寡聚体相互作用中的基本作用也得到了强调。最后,我们观察到有毒寡聚体与细胞膜的结合会显著影响 Arg-Gly-Asp 结合整合素等粘附分子的功能,而这种效应需要 GM1 中带负电荷的唾液酸部分的存在。